stocks

Stock Market Today: COVID's Intensifying 'Second Wave' Knocks Stocks Back

Another record high in COVID daily caseloads, as well as spiking hospitalizations and deaths, weighed on stocks Thursday.

The market's early-week euphoria over COVID vaccine progress has mostly run out amid more immediate-term worries about the virus itself.

The Washington Post reported late Wednesday that U.S. caseloads had spiked to yet another all-time high of 145,000. Hospitalizations eclipsed 65,000, and the daily death toll of 1,549 was the highest total since mid-May. New York City restaurants, bars and gyms face new restrictions starting Friday, and Chicago has announced a stay-at-home advisory starting Nov. 16.

The most recent weekly unemployment claims declined from 757,000 to a still-elevated 709,000, the Labor Department reported Thursday. Kenny Polcari, managing partner of Kace Capital Advisors, adds that "rising COVID-19 cases nationwide and the possibility of additional lockdowns could threaten the jobs recovery we've seen over the past few months."

The Dow Jones Industrial Average dropped 1.1% to 29,080.

Other action in the stock market today:

  • The S&P 500 fell 1.0% to 3,537.
  • The tech-heavy Nasdaq Composite fared a little better, declining 0.7% to 11,709.
  • The small-cap Russell 2000 plunged 1.8% to 1,706.
  • December gold contracts gained 0.6% to $1,873.30 per ounce.
  • U.S. crude oil settled at $41.12 per barrel, a 0.8% decline.

About That Value Rotation ...

Is the "great rotation" into value dead, or merely on pause? Well, many analysts remain confident in a vaccine sparking a switch in market leadership.

"(Vaccine) news, paired with the near-record valuation gap between value and growth stocks, could bode well for a sustained, multi-year rotation toward value outperformance," says Brent Fredberg, director of investments at Brandes Investment Partners.

But the market doesn't move in a straight line, and there's a lot of daylight between where we are now and when a vaccine will be approved and widely distributed. That's valuable time for investors to load up on value stocks if they're still confident in this eventual rotation.

Fund-minded investors can obtain inexpensive and diversified exposure to various value bundles via these seven great value ETFs. Meanwhile, if you prefer the concentrated oomph of stock picking, you can start with these bargain-priced Dividend Aristocrats.

But if you're looking for the most revered of value stocks, look for where the bulls are most crowding around. Each of these seven value stocks are cheaper than the broader market, and in most cases, cheaper than the value peer average and/or their sectormates ... and the analyst community is wild about them.

Most Popular

What Biden Will Do: 24 Policy Plays to Expect From the Next Administration
Politics

What Biden Will Do: 24 Policy Plays to Expect From the Next Administration

The Kiplinger Letter forecasts President-Elect Joe Biden’s biggest priorities -- and the likelihood of progress on them.
November 19, 2020
The 13 Best Healthcare Stocks to Buy for 2021
Kiplinger's Investing Outlook

The 13 Best Healthcare Stocks to Buy for 2021

Most of the best healthcare stocks for 2021 will have some sort of ties to COVID, whether it's producing a vaccine or cure, or benefiting from the vir…
November 20, 2020
16 Worst Gifts to Impulse Buy for the Holidays
shopping

16 Worst Gifts to Impulse Buy for the Holidays

Don't let those holiday sale promotions persuade you into buying something now that will be much cheaper later.
November 18, 2020

Recommended

Stock Market Today 12/4/20: What Lousy Job Numbers? Major Indices Shoot to New Highs
stocks

Stock Market Today 12/4/20: What Lousy Job Numbers? Major Indices Shoot to New Highs

Hope springs eternal for federal COVID stimulus, helping stocks rewrite the record book Friday despite a drab November payrolls report.
December 4, 2020
50 Top Stock Picks That Billionaires Loved in Q3
stocks

50 Top Stock Picks That Billionaires Loved in Q3

Billionaires, high-asset hedge funds and other institutional investors recently revealed these 50 companies as some of their top stock picks during th…
December 4, 2020
Stock Market Today 12/3/20: Investors Buy Stimulus Hopes, But Not With Both Hands
stocks

Stock Market Today 12/3/20: Investors Buy Stimulus Hopes, But Not With Both Hands

Investors seemed cautiously optimistic about Washington's tone on a COVID rescue package, though late news from Pfizer cut into Thursday's gains.
December 3, 2020
Stock Market Today 12/2/20: Stocks Fight to Extend Rally Despite Disappointing Payrolls
stocks

Stock Market Today 12/2/20: Stocks Fight to Extend Rally Despite Disappointing Payrolls

A weak ADP payrolls print took the life out of stocks Wednesday, but continued stimulus talks nudged a few major indices into the black by day's end.
December 3, 2020